AmberCRO Vice President and CEO had met with Tajikistan health care leaders on the 11-13 of July 2009 and agreement come in force between AmberCRO and Tajikistan responsible persons about supervising, submitting documents for Clinical Trials to the Tajikistan authorities by AmberCRO in Tajikistan.

Clinical Trials in Tajikistan.

• Motivation from the government side to allow performing Clinical trials in Tajikistan
• Motivation for doctors to take part into Clinical Trials
• Motivation for patients to participate into Clinical Trials (there are ~ 7 million inhabitants in Tajikistan)

---

AmberCRO together with the Collaboration partner will assist your company in determining key aspects of study design such as:

• Number and types of arms

• Sample size

• Randomization design

• Endpoints

• Interim analysis (superiority, futility, classic adaptive and Bayesian design, etc)

•  Adaptive elements (classical, group-sequential, Bayesian, etc.)

---

AmberCRO had participated into international conference "Biospring 2009", March 16-18 Milan, Italy

---

AmberCRO had participated into international conference "Biosquare 2009", March 9-11 Lion, France

---

AmberCRO is planning to open satellite office in Kazakhstan in the 4^th quarter of 2009 or 1^st quarter of 2010

AmberCRO Vice president attended training in Vienna 13^th - 17^th of October 2008 (Vienna School of Clinical Research)

---

AmberCRO Vice President attended conference "Optimizing Clinical trials 2008" in Amsterdam

---

AmberCRO Vice President attended conference "Optimizing Clinical trials 2007" on the 30th and 31st of May 2007 in Amsterdam

---

AmberCRO is providing ICH/GCP training to doctors and CRA's (see ICH GCP for web_ENG and ICH GCP for web_LAT)

---

AmberCRO is collaborating with CRO companies and freelance from different part of the world. Each of the AmberCRO collaboration partner (including freelance) has more than 3 years experience in Clinical Research field. AmberCRO has reliable partners in Ukraine and Russia.

---

AmberCRO is moving to its new office, located in Jaunmarupe. Address: Mazcenu Avenue 3, LV-2166, Riga region, Latvia.